Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Tandem Diabetes Care
(NASDAQ:TNDM)
Intraday
$34.50
2.77
[8.73%]
After-Hours
$34.50
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$34.50
2.77
[8.73%]
At close: Apr 23
$34.50
0
[0.00%]
After Hours: 4:14PM EDT
Get Report
Watch
Q1 2024 Earnings in 8 days from now on Thu May 2nd, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Tandem Diabetes Care Stock (NASDAQ:TNDM)
Tandem Diabetes Care Stock (NASDAQ: TNDM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care
Benzinga Insights
-
9 hours ago
Tandem Diabetes Care shares are trading higher. Stifel maintained its Buy rating on the stock and raised its PT rom $37 to $40.
Benzinga Newsdesk
-
11 hours ago
Stifel Maintains Buy on Tandem Diabetes Care, Raises Price Target to $40
Benzinga Newsdesk
-
11 hours ago
Wednesday, April 03, 2024
What 4 Analyst Ratings Have To Say About Tandem Diabetes Care
Benzinga Insights
-
Apr 3, 2024, 4:00PM
Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $38
Benzinga Newsdesk
-
Apr 3, 2024, 2:35PM
Tuesday, March 26, 2024
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
Piero Cingari
-
Mar 26, 2024, 2:08PM
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Mar 26, 2024, 10:36AM
Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $37
Benzinga Newsdesk
-
Mar 26, 2024, 10:15AM
Tandem Diabetes Care shares are trading higher after Stifel upgraded the stock from Hold to Buy.
Benzinga Newsdesk
-
Mar 26, 2024, 7:12AM
Stifel Upgrades Tandem Diabetes Care to Buy, Announces $37 Price Target
Benzinga Newsdesk
-
Mar 26, 2024, 4:40AM
Friday, March 15, 2024
Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $31
Benzinga Newsdesk
-
Mar 15, 2024, 11:16AM
Wednesday, March 06, 2024
Tandem Diabetes Care Prices Upsized Private Placement Of $275M 1.50% Convertible Senior Notes Due 2029
Benzinga Newsdesk
-
Mar 6, 2024, 2:53AM
Tuesday, March 05, 2024
Tandem Diabetes Care shares are trading lower after the company announced a proposed $250 million private placement of convertible notes due 2029.
Benzinga Newsdesk
-
Mar 5, 2024, 3:38PM
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 5, 2024, 1:11PM
Monday, March 04, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Mar 4, 2024, 4:32PM
Tandem Diabetes Care shares are trading lower after the company announced a proposed $250 million private placement of convertible notes due 2029.
Benzinga Newsdesk
-
Mar 4, 2024, 4:20PM
Tandem Diabetes Care Announces Proposed $250M Private Placement Of Convertible Notes Due 2029
Benzinga Newsdesk
-
Mar 4, 2024, 4:14PM
Friday, February 23, 2024
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Feb 23, 2024, 2:07PM
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Feb 23, 2024, 11:58AM
Thursday, February 22, 2024
Tandem Diabetes Care shares are trading higher amid volatility after the company reported Q4 financial results.
Benzinga Newsdesk
-
Feb 22, 2024, 11:01AM
Wednesday, February 21, 2024
Tandem Diabetes Care shares are trading lower after the company reported worse-than-expected Q4 financial results and issued Q1 revenue guidance below estimates.
Benzinga Newsdesk
-
Feb 21, 2024, 4:27PM
Tandem Diabetes Care Sees Q1 2024 Revenue $175M Vs $186.086M Est.
Benzinga Newsdesk
-
Feb 21, 2024, 4:11PM
Tandem Diabetes Care Sees FY24 Revenue $850M Vs $842.487M Est.
Benzinga Newsdesk
-
Feb 21, 2024, 4:11PM
Tandem Diabetes Care: Q4 Earnings Insights
Benzinga Insights
-
Feb 21, 2024, 4:10PM
Tandem Diabetes Care Q4 2023 GAAP EPS $(0.46) Misses $(0.27) Estimate, Sales $196.80M Miss $202.76M Estimate
Benzinga Newsdesk
-
Feb 21, 2024, 4:09PM
Earnings Scheduled For February 21, 2024
Benzinga Insights
-
Feb 21, 2024, 5:09AM
Tuesday, February 13, 2024
Tandem Diabetes Care Launches Tandem Mobi Insulin Delivery System
Benzinga Newsdesk
-
Feb 13, 2024, 8:38AM
Monday, February 05, 2024
Stifel Maintains Hold on Tandem Diabetes Care, Raises Price Target to $24
Benzinga Newsdesk
-
Feb 5, 2024, 4:19PM
Wednesday, January 24, 2024
Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand
Vandana Singh
-
Jan 24, 2024, 12:34PM
Monday, January 08, 2024
Tandem Diabetes Care To Integrate Automated Insulin Delivery System With Abbott's Freestyle Libre 2 Plus Sensor
Benzinga Newsdesk
-
Jan 8, 2024, 10:50AM
Tuesday, December 12, 2023
Tandem Diabetes Care Announces Full U.S. Launch Of Tandem Source, A New Diabetes Management Platform For Customers And Healthcare Providers
Benzinga Newsdesk
-
Dec 12, 2023, 4:16PM
Wednesday, December 06, 2023
Tandem Diabetes Care Announces Launch Of Updated t:slim X2 Insulin Pump Software In US
Benzinga Newsdesk
-
Dec 6, 2023, 8:39AM
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software With Dexcom G7 CGM Integration In U.S.
Benzinga Newsdesk
-
Dec 6, 2023, 8:39AM
Thursday, November 30, 2023
Board Member of Tandem Diabetes Care Purchased $94K In Stock
Benzinga Insights
-
Nov 30, 2023, 10:05AM
Monday, November 13, 2023
Shares of medical device and diabetes care stocks are trading higher in reaction to the presentation of SELECT data by Novo Nordisk. Raymond James said it did not believe there were any major surprises and the data could be seen as 'modestly de-risking.'
Benzinga Newsdesk
-
Nov 13, 2023, 11:38AM
On November 7, 2023, Tandem Diabetes Care And COO David B. Berger Determined That He Will Be Stepping Down From His Current Position Effective December 31, 2023 - Filing
Benzinga Newsdesk
-
Nov 13, 2023, 6:08AM
Thursday, November 02, 2023
Piper Sandler Maintains Overweight on Tandem Diabetes Care, Lowers Price Target to $25
Benzinga Newsdesk
-
Nov 2, 2023, 4:04PM
Green Wave Boosts Stocks, Bonds As Traders Embrace Fed's Stance, Await Apple Earnings: What's Driving Markets Thursday?
Shanthi Rexaline
-
Nov 2, 2023, 1:58PM
Tandem Diabetes Care shares are trading lower after the company reported worse-than-expected Q3 financial results.
Benzinga Newsdesk
-
Nov 2, 2023, 8:49AM
Wednesday, November 01, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Nov 1, 2023, 5:31PM
Tandem Diabetes Care shares are trading lower after the company reported worse-than-expected Q3 financial results.
Benzinga Newsdesk
-
Nov 1, 2023, 4:39PM
Tandem Diabetes Care Q3 2023 Adj EPS $(0.38) Misses $(0.34) Estimate, Sales $185.62M Miss $192.34M Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 4:14PM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
Monday, October 16, 2023
Leerink Partners Initiates Coverage On Tandem Diabetes Care with Market Perform Rating, Announces Price Target of $21
Benzinga Newsdesk
-
Oct 16, 2023, 11:57AM
Wednesday, October 11, 2023
Shares of diabetes and glucose monitoring stocks are trading lower. The sector may be down on the FDA's announcement of a Digital Health Advisory Committee as well as early signs of efficacy in Novo Nordisk's Ozempic kidney trial. The sector has been under pressure this year amid the popularity of weight loss drugs.
Benzinga Newsdesk
-
Oct 11, 2023, 3:38PM
Monday, October 02, 2023
Where Tandem Diabetes Care Stands With Analysts
Benzinga Insights
-
Oct 2, 2023, 4:00PM
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Friday, September 15, 2023
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Vandana Singh
-
Sep 15, 2023, 1:46PM
Shares of diabetes and glucose monitoring stocks are trading lower following a report suggesting Apple has named a leader for its team developing a glucose tracker. Additionally, Raymond James cut its price targets on Dexcom and Insulet.
Benzinga Newsdesk
-
Sep 15, 2023, 12:18PM
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 11, 2023, 1:38PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch